Concepedia
Statistics
Publications
5
Citations
258
H-Index
Active since
2015
Affiliations
Universität Hamburg(Current)
University Medical Center Hamburg-Eppendorf
Ablynx (Belgium)
Kerstin Schütze is an author at Universität Hamburg specializing in oncology, nanobodies, and cancer immunology.
Publications per year
2015–2020
Nanobodies effectively modulate the enzymatic activity of CD38 and allow specific imaging of CD38+ tumors in mouse models in vivo
William Fumey, Julia Koenigsdorf, Valentin Kunick et al. · Scientific Reports · 2017 · 66 citations · Full text
Life Sciences, Immunology, Oncology +15
Targeting CD38-Expressing Multiple Myeloma and Burkitt Lymphoma Cells In Vitro with Nanobody-Based Chimeric Antigen Receptors (Nb-CARs)
Julia Hambach, Kristoffer Riecken, Sophia Cichutek et al. · Cells · 2020 · 64 citations · Full text
Life Sciences, Molecular Biology, Oncology +17
Molecular imaging of tumors with nanobodies and antibodies: Timing and dosage are crucial factors for improved <i>in vivo</i> detection
Peter Bannas, Alexander Lenz, Valentin Kunick et al. · Contrast Media & Molecular Imaging · 2015 · 53 citations · Full text
Medicine, Molecular Biology, Oncology +17
CD38-Specific Biparatopic Heavy Chain Antibodies Display Potent Complement-Dependent Cytotoxicity Against Multiple Myeloma Cells
Kerstin Schütze, Katharina Petry, Julia Hambach et al. · Frontiers in Immunology · 2018 · 50 citations · Full text
Pharmacy, Immunology, Oncology +17
Nanobody-based CD38-specific heavy chain antibodies induce killing of multiple myeloma and other hematological malignancies
Levin Schriewer, Kerstin Schütze, Katharina Petry et al. · Theranostics · 2020 · 25 citations · Full text
Medicine, Immunology, Oncology +17
1–5 of 5